Paresh Vyas, Christian Récher, Hartmut Döhner, Adriano Venditti, Sam Salek, Samantha Nier, Blanca Boluda, Gaspar Aspas Requena, Raja Prince-Eladnani, Erika Borlenghi, Antonio Curti, Koen Theunissen, Alba Puyuelo, Ioana Codruta Rus, David de Leeuw, Emanuele Ammatuna, Lalit Saini, Johan Maertens, Andre Schuh, Dilza Camanho, Adam Sullivan, Anne-Marie De La Bigne, Mathilde Romagnoli, Bénédicte Cognet, Courtney DiNardo, Susana Vives. "ALIDHE: An ongoing open-label phase 3b study investigating ivosidenib with azacitidine in clinical practice in adult patients with newly diagnosed mutant isocitrate dehydrogenase 1 (mIDH1) Acute Myeloid Leukemia (AML) ineligible for intensive induction chemotherapy (IC)." Blood (2025). https://doi.org/10.1182/blood-2025-3443